Abstract

Paratesticular embryonal rhabdomyosarcoma (RMS) is a rare tumor arising from the mesenchymal tissues of the spermatic cord, epididymis, testis and testicular tunics. We report three cases of adult paratesticular RMS, two embryonic and one pleomorphic rhabdomyosarcoma. All the patients underwent diagnostic orchidectomy. The work up investigations revealed lung metastases. Chemotherapy with Ifosfamide and Doxorubicin was used in two cases, whereas Vincristin- Actinomycin D and Cyclophosphamide was received in one case. An objective partial response was reported in 2 cases, with complete response in one case. Paratesticular RMS is a rare and aggressive tumor. Because of the absence of protocols designed specifically for adult patients, it is necessary to follow therapeutic guidelines in pediatric protocols.

Highlights

  • Rhabdomyosarcoma (RMS) is a malignant tumor of mesenchymal origin thought to arise from cells committed to a skeletal muscle lineage

  • A 18-year-old patient who presented to the department of surgical urology with a painless scrotal mass, he underwent a left inguinal orchidectomy

  • A 19-year-old patient, presented to our oncology department, with paratesticular embryonic rhabdomyosarcoma diagnosed because a painless scrotal mass

Read more

Summary

Introduction

Rhabdomyosarcoma (RMS) is a malignant tumor of mesenchymal origin thought to arise from cells committed to a skeletal muscle lineage. The first documented case of spermatic cord sarcoma was described by Lesauvage in 1845 Since this date, few cases were reported in the literature especially in adult. A 18-year-old patient who presented to the department of surgical urology with a painless scrotal mass, he underwent a left inguinal orchidectomy. A 19-year-old patient, presented to our oncology department, with paratesticular embryonic rhabdomyosarcoma diagnosed because a painless scrotal mass. A 25-year-old patient presented to the department of surgical urology with a painless scrotal mass.

Discussion
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call